The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.
Nine plaintiffs – six pharma companies and two alliances of industry groups – have sued the government over the price negotiation provisions of the Inflation Reduction Act (IRA), employing
Novartis has responded to the inclusion of its heart failure blockbuster Entresto on the list of the first 10 drugs that will be subject to Medicare pricing negotiations,
The identity of the first 10 medicines that will be subject to the first round of Medicare pricing negotiations has been revealed and, as expected, some big brands are in
The Centers for Medicare and Medicaid Services (CMS) has made some minor changes to its plan to allow Medicare to negotiate some drug prices after a series of lawsuits fro